Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs RMD✓SelectedUSD · RMDGSK vs RMD performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs RMD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.9%
RMD return
+64.3%
Excess return
-11.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioRMDExcessAlpha
1D-1.6%-2.4%+0.8%-1.1%
7D-4.7%-0.8%-3.9%-4.6%
30D-4.7%-3.2%-1.5%-4.3%
3M-8.8%+3.3%-12.0%-9.6%
6M-4.6%+14.6%-19.3%-7.7%
YTD+1.0%-0.6%+1.6%+0.2%
1Y+6.9%-2.2%+9.1%+6.3%
All+52.9%+64.3%-11.3%+42.5%

Cumulative growth

Daily Returns

Daily percentage return beside RMD.

Daily Out/Under-Performance

Portfolio return minus RMD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × RMD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded RMD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling